Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1). Licensed therapeutic or vaccine products are not available to treat filovirus disease...

詳細記述

保存先:
書誌詳細
出版年:Nature
主要な著者: Warren, Travis K., Wells, Jay, Panchal, Rekha G., Stuthman, Kelly S., Garza, Nicole L., Van Tongeren, Sean A., Dong, Lian, Retterer, Cary J., Eaton, Brett P., Pegoraro, Gianluca, Honnold, Shelley, Bantia, Shanta, Kotian, Pravin, Chen, Xilin, Taubenheim, Brian R., Welch, Lisa S., Minning, Dena M., Babu, Yarlagadda S., Sheridan, William P., Bavari, Sina
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7095208/
https://ncbi.nlm.nih.gov/pubmed/24590073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature13027
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料